Investigational Drug Information for Dorzagliatin
✉ Email this page to a colleague
What is the development status for investigational drug Dorzagliatin?
Dorzagliatin is an investigational drug.
There have been 7 clinical trials for Dorzagliatin.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2022.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Glucose Intolerance, and Diabetes Mellitus. The leading clinical trial sponsors are Hua Medicine Limited, Chinese University of Hong Kong, and University of Virginia.
There are two US patents protecting this investigational drug and fifty-two international patents.
Summary for Dorzagliatin
| US Patents | 2 |
| International Patents | 52 |
| US Patent Applications | 21 |
| WIPO Patent Applications | 15 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 1 (2022-01-01) |
| Vendors | 37 |
Recent Clinical Trials for Dorzagliatin
| Title | Sponsor | Phase |
|---|---|---|
| Dorzagliatin and 1st Phase Insulin and Beta-cell Glucose Sensitivity in IGT and NGT | Chinese University of Hong Kong | Phase 1/Phase 2 |
| Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity | University of Virginia | Phase 3 |
| Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in Individuals With Recent-onset Type 2 Diabetes and Monogenic Diabetes | Chinese University of Hong Kong | Phase 2 |
Clinical Trial Summary for Dorzagliatin
Top disease conditions for Dorzagliatin
Top clinical trial sponsors for Dorzagliatin
US Patents for Dorzagliatin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Dorzagliatin | ⤷ Try a Trial | Pyrrolidinone glucokinase activators | Hoffmann-La Roche Inc. (Nutley, NJ) | ⤷ Try a Trial |
| Dorzagliatin | ⤷ Try a Trial | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1H-pyrazol-3-ylamine | HUA MEDICINE (Grand Gayman, KY) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Dorzagliatin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Dorzagliatin | Argentina | AR071474 | 2028-04-16 | ⤷ Try a Trial |
| Dorzagliatin | Austria | AT557017 | 2028-04-16 | ⤷ Try a Trial |
| Dorzagliatin | Australia | AU2009237794 | 2028-04-16 | ⤷ Try a Trial |
| Dorzagliatin | Brazil | BRPI0911035 | 2028-04-16 | ⤷ Try a Trial |
| Dorzagliatin | Canada | CA2720524 | 2028-04-16 | ⤷ Try a Trial |
| Dorzagliatin | Chile | CL2009000889 | 2028-04-16 | ⤷ Try a Trial |
| Dorzagliatin | China | CN102007118 | 2028-04-16 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
